CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: It suggested that Baicalein overcame CML CD34+ cells resistance to IM by successfully inhibiting DNMTl and inducing the progressive demethylation of SHP-1 in BM microenvironment.